Gene therapy on trial for eye disease – Australian Life Scientist

Gene therapy on trial for eye disease
Australian Life Scientist
A new gene therapy for wet aged-related macular degeneration (AMD), the most common cause of blindness in the developed world, has shown positive interim results in safety and efficacy tests. Wet AMD leads to rapid vision loss and costs up to $6

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment